European Medical (ALEMS) | Stock Overview & Key Data
European Medical Solutions S.à r.l. | Small-cap | Healthcare
European Medical Solutions S.à r.l. | Small-cap | Healthcare
European Medical Performance Comparison
Stock Range
Today's Range
Low: €4.70
High: €4.70
on August 8, 2025
52 Week Range
Low: €4.20
High: €7.53
on May 23, 2025
on August 8, 2024
All-Time High: €2,956.45 on February 27, 2017
Explore how other BE stocks compare to their 52-week ranges: View BE Market 52-Week Insights
Key Statistics
Market Cap
€19.5M
EPS
0.13
P/E Ratio (TTM)
35.38
Forward P/E
N/A
P/B Ratio
1.88
PEG Ratio
N/A
Div. Yield
N/A
ROE
5.40%
Beta
0.519
Debt to Equity
191.98
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
3.24%
Profit Margin
1.14%
Returns and Earnings
Return on Assets (TTM)
1.70%
Return on Equity (TTM)
5.40%
EBITDA
€3.8M
Net Income (TTM)
€546.0K
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€11.32
Quarterly Revenue Growth (YoY)
19.20%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| European Medical ALEMS | 19.47M Small-cap | 2.17% | 6.82% | -14.55% | -25.98% | -21.67% | -36.40% | -89.73% | -92.10% |
| Argenx SE ARGX | 36.23B Large-cap | -2.70% | 22.47% | 16.88% | -10.26% | -6.94% | 16.76% | 55.26% | 187.94% |
| UCB S.A UCB | 35.08B Large-cap | -0.19% | 8.47% | 21.66% | -3.50% | -3.58% | 17.07% | 152.26% | 80.18% |
| Celyad Oncology S.A CYAD | 16.16M Small-cap | -4.88% | 11.43% | -13.33% | -11.36% | -41.79% | 69.57% | -80.98% | -95.52% |
| Biosenic SA BIOS | 1.63M Small-cap | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -80.00% | -98.25% | -99.73% |
| Oxurion NV OXUR | 1.52M Small-cap | 0.00% | 0.00% | -57.14% | -86.36% | -88.00% | -97.00% | -100.00% | -100.00% |
Ownership & Short Interest
Insider Ownership
90.75%
Institutional Ownership
0.02%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
150
Average 90-Day Volume
98
European Medical Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in European Medical would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALEMS's 52-week high and low?
- In the last 52 weeks, European Medical reached a high of €7.53 (on August 8, 2024) and a low of €4.20 (on May 23, 2025).
- What is the market cap and P/E ratio for ALEMS?
- Curious about European Medical's size and valuation? Its market capitalization stands at 19.47M. When it comes to valuation, the P/E ratio (trailing twelve months) is 35.38, and the forward P/E (looking ahead) is N/A.
- Does ALEMS pay dividends? If so, what's the yield?
- As for dividends, European Medical isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are European Medical's main competitors or similar companies to consider before investing?
When looking at European Medical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Argenx SE
ARGX36.23B Healthcare Biotechnology 16.76% 55.26% UCB S.A
UCB35.08B Healthcare Biotechnology 17.07% 152.26% Celyad Oncology S.A
CYAD16.16M Healthcare Biotechnology 69.57% -80.98% Biosenic SA
BIOS1.63M Healthcare Biotechnology -80.00% -98.25% Oxurion NV
OXUR1.52M Healthcare Biotechnology -97.00% -100.00% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for European Medical Solutions S.à r.l.? (e.g., ROE, Debt/Equity)
- To get a sense of European Medical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.40%, the Debt to Equity ratio from the most recent quarter is 191.98, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALEMS?
- Looking at European Medical's growth, its revenue over the trailing twelve months (TTM) was €48M. Compared to the same quarter last year (YoY), quarterly revenue grew by 19.20%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALEMS stock is held by insiders and institutions?
- Wondering who owns European Medical stock? Company insiders (like executives and directors) hold about 90.75% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.02%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.